Earnings Call Insights: Takeda Pharmaceutical Company Limited (NYSE ... to the lack of prior transcript data. However, ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Net Income Growth 5Y: 28.35% Takeda Pharmaceutical Company Limited (NYSE:TAK) is a leading global biopharmaceutical company with a rich history dating back to 1781. It is the third-largest ...

JPMorgan JP Morgan sees strong growth for Ascentage Pharma, citing its late-stage cancer drugs. The biotech's 2024 sales surged 342% YoY, driven by a Takeda payment. Vandana Singh Pharmaceutical ...

Takeda's AI-powered "returning to growth" program has improved profit ... product candidate in partnership with a large pharmaceutical company (see image below). PTGX is also developing ...